Chemoinformaics analysis of OMEGA-HYDROXYEMODIN
| Molecular Weight | 286.239 | nRot | 1 |
| Heavy Atom Molecular Weight | 276.159 | nRig | 17 |
| Exact Molecular Weight | 286.048 | nRing | 3 |
| Solubility: LogS | -3.921 | nHRing | 0 |
| Solubility: LogP | 2.661 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 36.5299 |
| nHD | 4 | BPOL | 11.7681 |
| QED | 0.266 |
| Synth | 2.851 |
| Natural Product Likeliness | 1.418 |
| NR-PPAR-gamma | 0.915 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.872 |
| CACO-2 | -5.581 |
| MDCK | 0.000004 |
| BBB | 0.003 |
| PPB | 0.947441 |
| VDSS | 0.533 |
| FU | 0.07742 |
| CYP1A2-inh | 0.953 |
| CYP1A2-sub | 0.112 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.456 |
| CYP2c9-sub | 0.421 |
| CYP2d6-inh | 0.074 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.115 |
| CYP3a4-sub | 0.022 |
| CL | 7.044 |
| T12 | 0.906 |
| hERG | 0.015 |
| Ames | 0.428 |
| ROA | 0.014 |
| SkinSen | 0.94 |
| Carcinogencity | 0.031 |
| EI | 0.924 |
| Respiratory | 0.728 |
| NR-Aromatase | 0.149 |
| Antiviral | Yes |
| Prediction | 0.765019 |